Загрузка...
Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO)
BACKGROUND: Neuromyelitis optica (NMO) is a chronic autoimmune disease of the central nervous system (CNS). The main immunological feature of the disease is the presence of autoantibodies to Aquaporin 4 (AQP4+), identified in about 82 % of cases. Currently, there are no reliable biomarkers for monit...
Сохранить в:
| Опубликовано в: : | J Neuroinflammation |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4939003/ https://ncbi.nlm.nih.gov/pubmed/27393339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-016-0648-x |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|